RNS Number : 7061L
KRM22 PLC
06 June 2025
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Director Dealings

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, announces that on 5 June 2025, Sandy Broderick, Non-Executive Director of the Company, purchased 22,974 ordinary shares (the "Purchase") of 10 pence each in the capital of the Company ("Ordinary Shares").  

 

Following this transaction, Sandy Broderick will have a beneficial interest in 34,739 Ordinary Shares representing 0.1 per cent. of the issued share capital of the Company.

 

 

 

For further information please contact:

 

KRM22 plc                                                                                         

Garry Jones, Chairman

Dan Carter, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)                       

Stephen Keys / Isaac Hooper (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018.  The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management.  The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sandy Broderick

2.

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

KRM22 Plc

b)

LEI

213800IBCSBLSLJ9OD78

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 10 pence each ("Ordinary Shares")

Identification code

GB00BFM6WC61

b)

Nature of the transaction

Sale and purchase of Ordinary Shares

c)

Price(s) and volume(s)


Price(s)

Volume(s)

Purchase

£0.348

22,974

d)

Aggregated information:

·        Aggregated volume

·        Price

 

See 4c) above

e)

Date of the transaction

5 June 2025

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBELLBEQLFBBE